MARKET

LQDA

LQDA

Liquidia Corporation
NASDAQ
15.75
+0.49
+3.21%
After Hours: 15.86 +0.11 +0.72% 18:50 05/12 EDT
OPEN
15.63
PREV CLOSE
15.26
HIGH
16.27
LOW
15.33
VOLUME
1.07M
TURNOVER
--
52 WEEK HIGH
16.81
52 WEEK LOW
8.26
MARKET CAP
1.35B
P/E (TTM)
-9.5069
1D
5D
1M
3M
1Y
5Y
1D
Liquidia Technologies’ Earnings Call: Legal Wins and Financial Challenges
TipRanks · 4h ago
Liquidia Price Target Maintained With a $25.00/Share by Needham
Dow Jones · 12h ago
Needham Reiterates Buy on Liquidia, Maintains $25 Price Target
Benzinga · 13h ago
BUZZ-U.S. STOCKS ON THE MOVE-Fox, Manpower Group, US chipmakers
Reuters · 13h ago
Buy Rating for Liquidia Technologies Amid Legal Challenges and Market Potential
TipRanks · 14h ago
BUZZ-U.S. STOCKS ON THE MOVE-NRG Energy, US drugmakers, KindlyMD
Reuters · 16h ago
Where Liquidia Stands With Analysts
Benzinga · 16h ago
BUZZ-U.S. STOCKS ON THE MOVE-Oil firms, Apple, US big banks
Reuters · 17h ago
More
About LQDA
More
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operate through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.
Recently
Symbol
Price
%Change

Webull offers Liquidia Corp stock information, including NASDAQ: LQDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LQDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LQDA stock methods without spending real money on the virtual paper trading platform.